RxDoctor Payments Data

Manuel Pena

Naples, FLNPI 1518055821

Payments from drug & device makers

$9,112in general payments, 2019–2025

Across 218 payments — averaging $41.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$6K
  • Merz North America, Inc.$898
  • Revance Therapeutics, Inc.$384
  • Motiva USA, LLC$305
  • Galderma Laboratories, L.p.$282
  • Sientra, Inc.$272
  • plus $537 from 11 others

What the payments were for

  • Food & beverage$9,078100%
  • Education$340%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib47$689
ValacyclovirValacyclovir Hcl45$393
CefuroximeCefuroxime Axetil65$339
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen46$238
Gabapentin49$199
Ondansetron OdtOndansetron30$129
Mupirocin12$94
Lorazepam38$28

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →